Nirmeen Haniss-Youssef, PA-C

Nirmeen Haniss-Youssef practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Nirmeen Haniss-Youssef's NPI, 1750340246, was assigned on March 22, 2006. Nirmeen Haniss-Youssef holds California license PA16592.

Nirmeen Haniss-Youssef's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Nirmeen Haniss-Youssef's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Nirmeen Haniss-Youssef is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Nirmeen Haniss-Youssef to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nirmeen Haniss-Youssef practices, 6 sites in all. Vendor and product names are available with a free account.

Physician assistant is Nirmeen Haniss-Youssef's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Nirmeen Haniss-Youssef is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Nirmeen Haniss-Youssef is licensed in California.

CMS data shows 306 Medicare services from Nirmeen Haniss-Youssef across 6 procedure codes in 2024, for 323 Medicare patients. Medicare paid $26,281 for them.

CMS counts 323 Medicare patients who saw Nirmeen Haniss-Youssef in 2024. The largest group is 75 to 84, with 131 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nirmeen Haniss-Youssef's median patient age at 77, with 35% women.

In 2024, Nirmeen Haniss-Youssef wrote 404 Medicare Part D claims for 163 patients. 67% of them were for generic drugs. CMS names the drug for 332 of them, across 8 drugs with 11 or more claims each, at $113,160 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Nirmeen Haniss-Youssef for performance year 2024, reported as part of a group. Nirmeen Haniss-Youssef accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nirmeen Haniss-Youssef as offering telehealth.

CMS Open Payments shows 53 general payments to Nirmeen Haniss-Youssef from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 58% of the total. Medtronic, Inc. paid the most, $3,483.